Squalene epoxidase promotes pancreatic ductal adenocarcinoma tumorigenesis and drives gemcitabine resistance by activating the PI3K-Akt pathway

被引:0
|
作者
Liu, Lei [1 ]
Xu, Hui [2 ]
Huang, Xinyang [1 ]
Li, Weilin [3 ]
Jin, Yixun [1 ]
Zhang, Minmin [1 ]
Wang, Lifu [1 ]
Zou, Duowu [1 ]
机构
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Hangzhou, Zhejiang, Peoples R China
[3] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA
关键词
D O I
10.1136/gutjnl-2023-IDDF.68
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
IDDF2023-A
引用
收藏
页码:A76 / A77
页数:2
相关论文
共 50 条
  • [31] RRP9 promotes gemcitabine resistance in pancreatic cancer via activating AKT signaling pathway
    Zhang, Zhiqi
    Yu, Haitao
    Yao, Wenyan
    Zhu, Na
    Miao, Ran
    Liu, Zhiquan
    Song, Xuwei
    Xue, Chunhua
    Cai, Cheng
    Cheng, Ming
    Lin, Ke
    Qi, Dachuan
    CELL COMMUNICATION AND SIGNALING, 2022, 20 (01)
  • [32] A small nucleolar RNA, SNORD126, promotes adipogenesis in cells and rats by activating the PI3K-AKT pathway
    He, Yi
    Wu, Yu
    Mei, Bin
    Fang, Xianlong
    Cai, Guangzhen
    Cai, Ning
    Wu, Qiqi
    Huang, Zhao
    Ge, Chang
    Liang, Huifang
    Zhang, Bixiang
    Chen, Xiaoping
    Chu, Liang
    JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (04) : 3001 - 3014
  • [33] Centromere protein N promotes lung adenocarcinoma progression by activating PI3K/AKT signaling pathway
    Zheng, Yi
    You, Hui
    Duan, Jingzhu
    Chen, Biyu
    Wu, Chenlin
    Chen, Peipei
    Wang, Meifang
    GENES & GENOMICS, 2022, 44 (09) : 1039 - 1049
  • [34] Centromere protein N promotes lung adenocarcinoma progression by activating PI3K/AKT signaling pathway
    Yi Zheng
    Hui You
    Jingzhu Duan
    Biyu Chen
    Chenlin Wu
    Peipei Chen
    Meifang Wang
    Genes & Genomics, 2022, 44 : 1039 - 1049
  • [35] SDC1 promotes cisplatin resistance in hepatic carcinoma cells via PI3K-AKT pathway
    Liquan Yu
    Hong Xu
    Song Zhang
    Jiangming Chen
    Zhongshan Yu
    Human Cell, 2020, 33 : 721 - 729
  • [36] SDC1 promotes cisplatin resistance in hepatic carcinoma cells via PI3K-AKT pathway
    Yu, Liquan
    Xu, Hong
    Zhang, Song
    Chen, Jiangming
    Yu, Zhongshan
    HUMAN CELL, 2020, 33 (03) : 721 - 729
  • [37] Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion
    Shulkla, Sanjeev
    MacLennan, Gregory T.
    Hartman, Douglas J.
    Fu, Pingfu
    Resnick, Martin I.
    Gupta, Sanjay
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (07) : 1424 - 1432
  • [38] Targeting PI3K Pathway in Pancreatic Ductal Adenocarcinoma: Rationale and Progress
    Mehra, Siddharth
    Deshpande, Nilesh
    Nagathihalli, Nagaraj
    CANCERS, 2021, 13 (17)
  • [39] Targeting the PI3K-Akt pathway in kidney cancer
    Park, Jin-Young
    Lin, Pei-Yin
    Weiss, Robert H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (06) : 863 - 870
  • [40] Fam83D promotes tumorigenesis and gemcitabine resistance of pancreatic adenocarcinoma through the Wnt/β-catenin pathway
    Hua, Yong-Qiang
    Zhang, Ke
    Sheng, Jie
    Ning, Zhou-Yu
    Li, Ye
    Shi, Wei-Dong
    Liu, Lu-Ming
    LIFE SCIENCES, 2021, 287